Author

D. R. Carter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Balachandran· 1 shared A. Shah· 1 shared B. B. Cheung· 1 shared B. Gottgens· 1 shared C. Zhang· 1 shared D. Beck· 1 shared D. Chacon· 1 shared F. Zanini· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Balachandran

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells

J. A. Thoms, K. Knezevic, G. Harvey, Y. Huang, J. Seneviratne, D. R. Carter, S. Subramanian, J. Skhinas, D. Chacon, A. Shah, I. de Jong, D. Beck, B. Gottgens, J. Larsson, J. W. Wong, , J. E. Pimanda

The paper identifies a GATA2, TAL1, ERG regulatory circuit that promotes erythroid transition in both healthy and leukemic stem cells, showing its persistence in AML with minor alterations.

bioRxiv · Oct 26, 2020Cancer Biology

Single-cell RNA-sequencing of peripheral neuroblastic tumors reveals an aggressive transitional cell state at the junction of an adrenergic-mesenchymal transdifferentiation trajectory

X. Yuan, J. A. Seneviratne, S. Du, Y. Xu, Y. Chen, Q. Jin, X. Jin, A. Balachandran, S. Huang, Y. Xu, Y. Zhai, L. Lu, M. Tang, Y. Dong, B. B. Cheung, , D. R. Carter

This study uses single-cell RNA-sequencing to identify a transitional cell state in peripheral neuroblastic tumors associated with poor prognosis and therapeutic targets.

bioRxiv · May 15, 2020 · PreprintCancer Biology